NDC 50090-0495-01 - GLYBURIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0495
- Requested NDC
- 50090-0495-01
- Package NDCs from labels
- 50090-0495-8, 50090-0495-0, 50090-0495-1, 50090-0495-9, 50090-0495-2, 50090-0495-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-02-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLYBURIDE - A-S Medication Solutions | A-S Medication Solutions | 2023-02-04 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-0495-0 | 2023-02-07 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-1 | 2023-02-07 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-2 | 2023-02-07 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-8 | 2023-02-07 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-9 | 2023-02-07 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-0 | 2023-01-30 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-1 | 2023-01-30 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-2 | 2023-01-30 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-8 | 2023-01-30 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
| 50090-0495-9 | 2023-01-30 | Glyburide Tablets, USP 1.25, 2.5, and 5 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0495-0 | GLYBURIDE | 30 in 1 BOTTLE | TABLET | 30 | 11 | |
| 50090-0495-1 | GLYBURIDE | 100 in 1 BOTTLE | TABLET | 100 | 11 | |
| 50090-0495-2 | GLYBURIDE | 60 in 1 BOTTLE | TABLET | 60 | 11 | |
| 50090-0495-8 | GLYBURIDE | 200 in 1 BOTTLE | TABLET | 200 | 11 | |
| 50090-0495-9 | GLYBURIDE | 90 in 1 BOTTLE | TABLET | 90 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0495 | GLYBURIDE TABLET [A-S MEDICATION SOLUTIONS] | 11 | Current NDC, Legacy NDC, 5 package rows | 20230208_3c91a408-973b-4572-832f-515f61d5be1f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0495-0 | EA - Each | 50090-0495 | b9e244de-8e38-44d8-86d1-57407ce219e9 | 1 | 2018-09-05 |
| 50090-0495-1 | EA - Each | 50090-0495 | e0d9b6a1-309d-4f09-952f-954336cb1acd | 1 | 2021-08-05 |
| 50090-0495-2 | EA - Each | 50090-0495 | 92d9a2e6-fc66-4a28-a0db-6623a05bab2f | 1 | 2018-09-05 |
| 50090-0495-8 | EA - Each | 50090-0495 | f32350d6-586a-4393-987e-5c30e9c7ef91 | 1 | 2018-09-05 |
| 50090-0495-9 | EA - Each | 50090-0495 | d0272aed-6044-4f1d-ae7f-b8f68b3b32e4 | 1 | 2021-08-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glyburide | GLYBURIDE | NuCare Pharmaceuticals,Inc. | 901c50d5-31e7-b073-e053-2995a90abfeb | 2024-06-19 | Adverse reactions | ANDA090937 310537 SX6K58TVWC |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 7facb5ac-c1d5-43b4-e053-2991aa0a2a7b | 2024-06-12 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | 8f2951ab-20c3-4216-b250-4c6a62d32203 | 2024-05-30 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide | GLYBURIDE | A-S Medication Solutions | d090f978-b1a5-4db7-951d-3f32dd06966c | 2024-01-02 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | A-S Medication Solutions | 7a280f88-26d4-4fe5-a89b-a6f1d90ed3cd | 2023-12-03 | Adverse reactions | ANDA090937 310534 SX6K58TVWC |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | H3R47K3TBD |
| Glyburide | GLYBURIDE | A-S Medication Solutions | 922d1080-52c6-41e4-a310-533d8ca18594 | 2023-08-28 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | A-S Medication Solutions | 3c91a408-973b-4572-832f-515f61d5be1f | 2023-02-04 | Adverse reactions | ANDA090937 50090-0495-1 50090-0495-0 50090-0495-9 50090-0495-8 50090-0495-2 50090-0495 50090049501 310537 d7312022-17ca-4251-a684-6045f7841266 3c91a408-973b-4572-832f-515f61d5be1f SX6K58TVWC |
| Glyburide | GLYBURIDE | Teva Pharmaceuticals USA, Inc. | e84c0dfc-a4e9-4c89-b6ea-45732eb412f5 | 2023-01-09 | Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide | GLYBURIDE | Cadila Pharmaceuticals Limited | ea7a055b-64f0-46bf-aa8e-4a2ef5c3c035 | 2022-12-29 | Warnings, Adverse reactions | 310537 197737 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | Modavar Pharmaceuticals LLC | a5de0ef6-4c8b-40ab-b0ed-2003a8086750 | 2022-12-29 | Warnings, Adverse reactions | 310537 197737 310534 SX6K58TVWC |
| glyburide | GLYBURIDE | Zydus Lifesciences Limited | 5d0e406f-285d-4716-8971-82f665345517 | 2022-11-16 | Adverse reactions | 310537 197737 310534 SX6K58TVWC |
| glyburide | GLYBURIDE | Zydus Pharmaceuticals (USA) Inc. | 87781ea8-62ec-483c-a4dd-8c965ce59485 | 2022-11-16 | Adverse reactions | 310537 197737 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | TEVA Pharmaceuticals USA Inc | 50d16f1d-c814-4411-8749-62561321ecce | 2021-07-01 | Warnings, Adverse reactions | 310537 197737 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | Proficient Rx LP | ec45f0d8-cab8-4822-895b-17bb443a4f98 | 2019-11-01 | Warnings, Adverse reactions | 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | Proficient Rx LP | b292cb9b-7348-4c07-a871-bc091229fdf8 | 2019-11-01 | Adverse reactions | ANDA090937 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | Proficient Rx LP | 240c3ac6-9aab-4185-994e-a0254e3aeb61 | 2019-11-01 | Adverse reactions | ANDA090937 310537 SX6K58TVWC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.